Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Aldeyra Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 Feb 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Aldeyra Therapeutics Inc (ALDX-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 Feb 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for ALDX

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

07 Feb 2016 ValuEngine, Inc. 11 $25.00

ALDEXA THERAPEUTICS INC (ALDX=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

06 Feb 2016 Pechala's Reports 2 $25.00

ALDX – Last patient for the NS2 in allergic conjunctivitis in Phase II trial completed dosing—ahead of our projection

This morning, ALDX reported that the NS2 in allergic conjunctivitis Phase II trial has completed dosing the last patient, and...

16 Dec 2015 Laidlaw & Company 7 $25.00

ALDEXA THERAPEUTICS INC (ALDX=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

14 Nov 2015 Pechala's Reports 2 $25.00

ALDX 3Q15: The stage is being set for potential releases of clinical data from the three phase II trials in 2016

ALDX reported 3Q15 financial results with a net loss of ($3.3MM) or net loss per share of ($0.35). ALDX ended 3Q15 with cash ...

12 Nov 2015 Laidlaw & Company 7 $25.00

ALDX: Management update provided renewed confidence with multiple developments in place

After a recent discussion with ALDX management, we walked away with renewed confidence that several clinical developments are...

16 Sep 2015 Laidlaw & Company 7 $25.00

ALDEXA THERAPEUTICS INC (ALDX) 12-months forecast

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

23 Aug 2015 Pechala's Reports 1 $15.00

ALDEXA THERAPEUTICS INC (ALDX) - REPORT FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

22 Aug 2015 Pechala's Reports 1 $25.00